It seems that there is no content provided for summarization. Please share the text or details you'd like summarized, and I'll be happy to assist!
Takeda Pharmaceutical Company (TAK) reported a negative EPS surprise in its most recent quarterly earnings. For the most recent quarter, Takeda Pharmaceutical Company's actual EPS was -$65.35, missing the estimate of -$55.79 per share, resulting in a -17.13% surprise.
📡️ Health Care
Earnings Surprise
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
